FDA approves drug that can slow early-stage Alzheimer's

Name: FDA approves drug that can slow early-stage Alzheimer's
Uploaded: 2023-01-10T17:00:25Z
Duration: 5 min 10 s
Description: A promising Alzheimer's drug is now getting fast-tracked by the FDA. Dr. Paul E. Schulz, the leading neurologist with UTHealth Houston and the McGovern School of Medicine, explains the benefits of Leqembi.

A promising Alzheimer's drug is now getting fast-tracked by the FDA. Dr. Paul E. Schulz, the leading neurologist with UTHealth Houston and the McGovern School of Medicine, explains the benefits of Leqembi.

Posted January 10, 2023 11:00am CST